Drug-resistant temporal lobe epilepsy: Seizure outcome in children versus adults
View abstract on PubMed
Summary
This summary is machine-generated.Children with temporal lobe epilepsy (TLE) experience better surgical outcomes than adults, highlighting the importance of early intervention. Catching them young can significantly improve seizure freedom and long-term results.
Area Of Science
- Neurology
- Epileptology
- Pediatric Neurology
Background
- Temporal lobe epilepsy (TLE) is the most common focal epilepsy, with many drug-resistant cases eligible for surgery.
- While pediatric TLE surgery outcomes are often favorable, direct comparisons with adult outcomes using the same surgical procedures are limited.
Purpose Of The Study
- To compare long-term seizure outcomes between pediatric and adult patients undergoing TLE surgery.
- To identify prognostic factors influencing surgical success in both age groups.
Main Methods
- A cohort of 684 patients (127 children, 557 adults) underwent standard anterior temporal lobectomy.
- Presurgical evaluation included video EEG and neuroimaging; seizure freedom was the primary outcome.
- Logistic regression and Kaplan-Meier curves were used to analyze predictors and long-term seizure-free survival.
Main Results
- Children had shorter epilepsy duration (8.38 vs. 19.2 years) and better seizure outcomes (57.4% vs. 45.6%) compared to adults.
- Median seizure-free survival was longer in children (120 months) than adults (72 months).
- Predictors of poor outcome in adults included specific auras and EEG findings; febrile seizures predicted favorable outcomes in both groups. Neoplasia was protective in children, while psychiatric comorbidities predicted recurrence.
Conclusions
- Pediatric patients demonstrate superior long-term seizure control after TLE surgery compared to adults.
- Earlier surgical intervention in children, evidenced by shorter epilepsy duration, contributes to better outcomes.
- The findings underscore the principle of "time is brain" in epilepsy, advocating for early surgical referral to prevent network expansion and improve seizure control.
Related Concept Videos
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Focal aware seizures: In these seizures, the person remains conscious...
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

